Profile of Olaparib in the Treatment of Advanced Ovarian Cancer

International Journal of Women's Health - New Zealand
doi 10.2147/ijwh.s55906
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Emerging Treatment Options for Recurrent Ovarian Cancer: The Potential Role of Olaparib

OncoTargets and Therapy
OncologyPharmacology
2013English

Treatment Decisions in Advanced Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Olaparib in the Therapy of Advanced Ovarian Cancer: First Real World Experiences in Safety and Efficacy From China

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Efficacy of Aidi Injection Combined With Chemotherapy in the Treatment of Advanced Epithelial Ovarian Cancer

DEStech Transactions on Biology and Health
2018English

Inhibition of MUS81 Improves the Chemical Sensitivity of Olaparib by Regulating McM2 in Epithelial Ovarian Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Bevacizumab in the Treatment of Ovarian Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2011English

Profile of Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2010English

Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

New Strategies in Ovarian Cancer: Translating the Molecular Complexity of Ovarian Cancer Into Treatment Advances

Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy